[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE0001865D0 - Management of septic shock - Google Patents

Management of septic shock

Info

Publication number
SE0001865D0
SE0001865D0 SE0001865A SE0001865A SE0001865D0 SE 0001865 D0 SE0001865 D0 SE 0001865D0 SE 0001865 A SE0001865 A SE 0001865A SE 0001865 A SE0001865 A SE 0001865A SE 0001865 D0 SE0001865 D0 SE 0001865D0
Authority
SE
Sweden
Prior art keywords
septic shock
pharmaceutical composition
management
sterile pharmaceutical
medicament
Prior art date
Application number
SE0001865A
Other languages
English (en)
Inventor
Arne Eek
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0001865A priority Critical patent/SE0001865D0/sv
Publication of SE0001865D0 publication Critical patent/SE0001865D0/sv
Priority to US09/849,591 priority patent/US20020037933A1/en
Priority to IL15247101A priority patent/IL152471A0/xx
Priority to CN01809726A priority patent/CN1430509A/zh
Priority to AU2001254990A priority patent/AU2001254990A1/en
Priority to PCT/GB2001/002117 priority patent/WO2001087289A2/en
Priority to EP01928126A priority patent/EP1296664A2/en
Priority to MXPA02011240A priority patent/MXPA02011240A/es
Priority to CA002407540A priority patent/CA2407540A1/en
Priority to JP2001583757A priority patent/JP2003533476A/ja
Priority to KR1020027015536A priority patent/KR20020097482A/ko
Priority to BR0110982-0A priority patent/BR0110982A/pt
Priority to ZA200208893A priority patent/ZA200208893B/en
Priority to NO20025530A priority patent/NO20025530L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0001865A 2000-05-19 2000-05-19 Management of septic shock SE0001865D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock
US09/849,591 US20020037933A1 (en) 2000-05-19 2001-05-07 Management of septic shock
BR0110982-0A BR0110982A (pt) 2000-05-19 2001-05-15 Composição farmacêutica estéril para administração parenteral, uso do composto 2,6-diisopropil-fenol (propofol), uso de uma composição farmacêutica estéril para administração parenteral, método de manejo do choque séptico, e, método de contraposição à deterioração induzida por endotoxina da tensão de oxigênio arterial
EP01928126A EP1296664A2 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
CN01809726A CN1430509A (zh) 2000-05-19 2001-05-15 控制败血症性休克
AU2001254990A AU2001254990A1 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
PCT/GB2001/002117 WO2001087289A2 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
IL15247101A IL152471A0 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
MXPA02011240A MXPA02011240A (es) 2000-05-19 2001-05-15 Manejo de choque septico.
CA002407540A CA2407540A1 (en) 2000-05-19 2001-05-15 Propofol for treatment of sepsis
JP2001583757A JP2003533476A (ja) 2000-05-19 2001-05-15 敗血症ショックの治療
KR1020027015536A KR20020097482A (ko) 2000-05-19 2001-05-15 패혈증 치료용 프로포폴
ZA200208893A ZA200208893B (en) 2000-05-19 2002-11-01 Propofol for treatment of sepsis.
NO20025530A NO20025530L (no) 2000-05-19 2002-11-18 Håndtering av septisk sjokk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Publications (1)

Publication Number Publication Date
SE0001865D0 true SE0001865D0 (sv) 2000-05-19

Family

ID=20279747

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001865A SE0001865D0 (sv) 2000-05-19 2000-05-19 Management of septic shock

Country Status (14)

Country Link
US (1) US20020037933A1 (sv)
EP (1) EP1296664A2 (sv)
JP (1) JP2003533476A (sv)
KR (1) KR20020097482A (sv)
CN (1) CN1430509A (sv)
AU (1) AU2001254990A1 (sv)
BR (1) BR0110982A (sv)
CA (1) CA2407540A1 (sv)
IL (1) IL152471A0 (sv)
MX (1) MXPA02011240A (sv)
NO (1) NO20025530L (sv)
SE (1) SE0001865D0 (sv)
WO (1) WO2001087289A2 (sv)
ZA (1) ZA200208893B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2211151T3 (es) * 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
BR0308857A (pt) * 2002-04-08 2005-01-04 Guilford Pharm Inc Composições farmacêuticas contendo promedicamentos de propofol, solúveis em água, e métodos de administrar os mesmos
AU2003222491A1 (en) * 2002-05-02 2003-12-31 Fdl, Inc. Novel parenteral composition comprising propofol
BRPI0614084A2 (pt) * 2005-08-05 2011-03-09 Bharat Serums & Vaccines Ltd composição estável de emulsão de óleo-em-água de propofol, administrável por via intranovesa; e processo de preparação de uma composição
US7727730B2 (en) * 2005-12-09 2010-06-01 Corgenix Medical Corporation Methods and kits for detection of thromboxane A2 metabolites
WO2011161687A1 (en) * 2010-06-23 2011-12-29 Harman Finochem Limited Process for preparing extra pure 2, 6-diisopropyl phenol
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
CN109470762B (zh) * 2017-09-07 2020-12-29 中国科学院大连化学物理研究所 一种准确识别丙泊酚注射液是否过期的方法
JP2022507380A (ja) * 2018-11-15 2022-01-18 フェリング ベスローテン フェンノートシャップ 敗血症を治療するための化合物、組成物及び方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
EP1296664A2 (en) 2003-04-02
AU2001254990A1 (en) 2001-11-26
MXPA02011240A (es) 2003-03-10
ZA200208893B (en) 2004-02-19
NO20025530L (no) 2003-01-14
WO2001087289A2 (en) 2001-11-22
BR0110982A (pt) 2003-04-08
KR20020097482A (ko) 2002-12-31
CN1430509A (zh) 2003-07-16
WO2001087289A3 (en) 2002-05-16
JP2003533476A (ja) 2003-11-11
US20020037933A1 (en) 2002-03-28
CA2407540A1 (en) 2001-11-22
NO20025530D0 (no) 2002-11-18
IL152471A0 (en) 2003-05-29

Similar Documents

Publication Publication Date Title
BR9907832A (pt) Composição de propofol contendo sulfito
BR9913221A (pt) Composições catalisadoras sustentadas altamente ativas
SE0301888D0 (sv) New use VII
PA8486001A1 (es) Composiciones de celecoxib
IS2750B (is) Leiðarafesting
UY26092A1 (es) Uso de inhibidores de cyp2d6 en terapias de combinacion
PA8548001A1 (es) Derivados aromaticos de acidos dicarboxilicos
ID28263A (id) DIPEPTIDA OKSAMIL TERMODIFIKASI C-TERMINAL SEBAGAI PENGHAMBAT PADA KELUARGA ICE-ced-3 DARI PROTEASE SISTEINA
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
SE0301882D0 (sv) New use I
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
CO5251404A1 (es) Compuestos antibioticos de azalida
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
DE60118225D1 (de) Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
SE0001865D0 (sv) Management of septic shock
ECSP066548A (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica
EA200300047A1 (ru) Прозрачное водное анестезирующее средство
KR960700217A (ko) 액체 페놀성 산화방지제
BR0000544A (pt) Poliolefinas de metaloceno estabilizadas
AR043253A1 (es) 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas
UY27394A1 (es) Pedidos con actividad anti- angiogéna.
CO5280199A1 (es) Composicion
SE0301885D0 (sv) New use IV
DK1128820T3 (da) Farmaceutisk blanding omfattende en kombination af en profen og andre aktive forbindelser